Peak Serum AST Is a Better Predictor of Acute Liver Graft Injury after Liver Transplantation When Adjusted for Donor/Recipient BSA Size Mismatch (ASTi)
Table 1
Recipient and donor variables.
Variables
Mean ± SEM
(N †)
Recipient
Age
52.8 ± 0.42
(717)
Percentages of male (%)
31.6%
(717)
Standard liver volume (mL)
1086.5 ± 7.1
(717)
Cause of end-stage liver disease
(717)
HCC
27.8%
HBV
8.4%
HCV
51.3%
Alcoholic
20.2%
PBC/PSC
1.0%
AIH
3.2%
Cryptogenic
1.4%
MELD
21.6 ± 0.3
(717)
PT (sec)
18.3 ± 0.2
(709)
Fibrinogen (mg/dL)
194.4 ± 5.3
(445)
Creatinine (mg/dL)
1.3 ± 0.0
(710)
Total bilirubin (mg/dL)
7.4 ± 0.4
(704)
Sodium (mEq/L)
136.7 ± 0.2
(710)
Platelet (×103 cells/mL)
99.1 ± 2.9
(711)
Donor
Age
41.1 ± 0.7
(717)
Percentages of male (%)
40.0%
(717)
Standard liver volume (mL)
1053.1 ± 6.9
(717)
Cause of death
(717)
Anoxia (%)
9.5%
Cerebrovascular accident (%)
7.1%
Cold ischemia time (min)
413.9 ± 3.9
(713)
Warm ischemia time (min)
39.6 ± 0.4
(711)
Donor risk index
1.78 ± 0.01
(670)
BSAi (donor/recipient)
0.99 ± 0.01
(717)
Data are means ± SEM or percentages. Number of patients with data available. Donor risk index without height [10] AIH: autoimmune hepatitis; MELD: BSAi: body surface area index [8]; HBV: hepatitis B virus; HCC: hepatocellular carcinoma; HCV: hepatitis C virus; models for end-stage liver disease; PBC: primary biliary cirrhosis; PSC: primary sclerosing cholangitis; PT: prothrombin time.
